You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 4, 2025

Drug Price Trends for NDC 69230-0201


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 69230-0201

Drug Name NDC Price/Unit ($) Unit Date
FEXOFENADINE HCL 60 MG TABLET 69230-0201-05 0.16896 EACH 2024-12-18
FEXOFENADINE HCL 60 MG TABLET 69230-0201-05 0.16045 EACH 2024-11-20
FEXOFENADINE HCL 60 MG TABLET 69230-0201-05 0.17133 EACH 2024-10-23
FEXOFENADINE HCL 60 MG TABLET 69230-0201-05 0.16481 EACH 2024-09-18
FEXOFENADINE HCL 60 MG TABLET 69230-0201-05 0.17890 EACH 2024-08-21
FEXOFENADINE HCL 60 MG TABLET 69230-0201-05 0.13136 EACH 2024-07-17
FEXOFENADINE HCL 60 MG TABLET 69230-0201-05 0.18342 EACH 2024-06-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 69230-0201

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

69230-0201 Market Analysis and Financial Projection

Market Analysis and Price Projections for Drug NDC: 69230-0201

Understanding the National Drug Code (NDC)

To analyze the market and project prices for a specific drug identified by its National Drug Code (NDC), it is crucial to understand what the NDC represents. The NDC is a unique, three-segment number that identifies the labeler, product, and trade package size of a drug. For the NDC 69230-0201, the first segment (69230) is the labeler code assigned by the FDA, the second segment (020) identifies the specific product, and the third segment (1) identifies the package size and type[1][5].

Market Context

Prescription Drug Price Trends

The pharmaceutical market, particularly for prescription drugs, has seen significant price fluctuations over recent years. From January 2022 to January 2023, more than 4,200 drug products experienced price increases, with an average increase of 15.2% or $590 per drug product. This trend indicates that drug prices can change substantially and frequently[2].

Global Price Comparisons

In the United States, prescription drug prices are notably higher compared to other countries. The average price per unit in the U.S. is 5.5 times higher than in the OECD (excluding the U.S.) and 7.7 times higher than in the rest of the world. This disparity highlights the unique pricing environment in the U.S. market[4].

Price Increase Patterns

Percentage and Dollar Value Increases

Price increases for prescription drugs can vary widely. For instance, from January 2022 to January 2023, single-source drugs saw an average price increase of 7.4% ($958), while multi-source drugs experienced an average increase of 26.0% ($69). The highest percentage increase during this period was for a drug treating high blood pressure, which saw a price increase of over 3,500%[2].

Impact of Inflation and Regulatory Changes

Price increases often exceed the rate of inflation. For example, the average price increase from January 2022 to January 2023 was 15.2%, significantly higher than the inflation rate. Regulatory changes, such as those under the Inflation Reduction Act (IRA), may also impact drug pricing by introducing inflation rebates for certain drugs[2].

Specific Analysis for NDC 69230-0201

Identifying the Drug

To conduct a detailed analysis, one must identify the specific drug associated with the NDC 69230-0201. This involves checking the FDA's National Drug Code Directory or other pharmaceutical databases to determine the drug's name, its therapeutic use, and its current market status.

Historical Price Data

Reviewing historical price data for the drug is essential. This can be obtained from databases that track drug prices, such as those maintained by the FDA or private analytics firms. Analyzing past price changes can help predict future trends.

Market Demand and Competition

Understanding the market demand and competitive landscape is crucial. If the drug is used to treat a common condition and has multiple competitors, price increases might be more modest due to market pressures. Conversely, if the drug is for a rare condition or has limited competition, price increases could be more significant.

Regulatory and Clinical Trial Impacts

Regulatory changes and advancements in clinical trials can significantly impact drug prices. For instance, if a drug is part of an accelerated clinical trial design or benefits from new regulatory frameworks, its market position and pricing could be affected[3].

Price Projection Considerations

Current Pricing Environment

Given the current pricing environment, where drug prices are increasing at rates often exceeding inflation, it is likely that the price of the drug associated with NDC 69230-0201 will also increase. The average price increase of 15.2% observed from January 2022 to January 2023 could serve as a benchmark.

Specific Drug Characteristics

The specific characteristics of the drug, such as its therapeutic use, market demand, and competition, will influence its price projection. If the drug is critical for treating a condition with limited alternatives, it may experience higher price increases.

Future Regulatory Changes

Any upcoming regulatory changes, such as those related to the IRA or other healthcare policies, could impact the pricing of the drug. These changes might introduce price caps or rebates that could mitigate future price increases.

Example Price Projection

Assuming the drug associated with NDC 69230-0201 is a prescription drug with moderate competition and significant market demand, here is a hypothetical price projection:

  • Current Price: $100 per unit (hypothetical)
  • Historical Increase Rate: 10% per year (based on average increases)
  • Projected Increase Rate: 12% per year (considering current trends and potential regulatory impacts)
  • Projected Price in 2025: $112 per unit (after a 12% increase from the current price)

Key Takeaways

  • Understanding NDC: The NDC is a critical identifier for drugs, helping in market analysis and price tracking.
  • Price Trends: Prescription drug prices are increasing, often exceeding inflation rates.
  • Market and Regulatory Factors: Market demand, competition, and regulatory changes significantly influence drug prices.
  • Specific Drug Analysis: Identifying the drug and analyzing its historical price data, market demand, and regulatory environment is essential for accurate price projections.

FAQs

Q: What does the National Drug Code (NDC) represent? A: The NDC is a unique, three-segment number that identifies the labeler, product, and trade package size of a drug.

Q: Why do prescription drug prices in the U.S. differ significantly from other countries? A: Prescription drug prices in the U.S. are higher due to various factors, including market dynamics, regulatory environments, and healthcare policies.

Q: How often can drug manufacturers change the list prices of their drugs? A: Drug manufacturers can change the list prices of their drugs at any time after launch.

Q: What impact do regulatory changes have on drug prices? A: Regulatory changes, such as those under the Inflation Reduction Act, can introduce price caps or rebates, affecting future price increases.

Q: How can one project future drug prices accurately? A: Accurate price projections require analyzing historical price data, market demand, competition, and potential regulatory impacts.

Sources

  1. FDA - National Drug Code Database Background Information
  2. ASPE - Changes in the List Prices of Prescription Drugs, 2017-2023
  3. TFS CRO - 5 Predictions for the Biopharma and Biotech Industries in 2025
  4. ASPE - International Market Size and Prices

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.